TRIB (Trinity Biotech plc) Stock Analysis - Financials

Trinity Biotech plc (TRIB) is a publicly traded Healthcare sector company. As of May 21, 2026, TRIB trades at $0.59 with a market cap of $11.54M and a P/E ratio of 0.00. TRIB moved +6.65% today. Year to date, TRIB is -20.85%; over the trailing twelve months it is -25.11%. Its 52-week range spans $0.48 to $3.44. Rallies surfaces TRIB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are TRIB's key financials?

TRIB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TRIB recently traded at $0.59. Market cap is $11.54M. P/E ratio is 0.00. Revenue is $0.

TRIB Key Metrics

Key financial metrics for TRIB
MetricValue
Price$0.59
Market Cap$11.54M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.22%
52-Week High$3.44
52-Week Low$0.48
Volume170
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest TRIB News

Recent TRIB Insider Trades

  • ROBERT R MCCORMICK TRIBUNE FOUNDATION sold 17.80K (~$924.52K) on Feb 18, 2004.
  • ROBERT R MCCORMICK TRIBUNE FOUNDATION sold 92.00K (~$4.82M) on Feb 17, 2004.
  • ROBERT R MCCORMICK TRIBUNE FOUNDATION sold 65.20K (~$3.39M) on Feb 13, 2004.

TRIB Analyst Consensus

TRIB analyst coverage data. Average price target: $0.00.

Common questions about TRIB

What are TRIB's key financials?
TRIB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TRIB recently traded at $0.59. Market cap is $11.54M. P/E ratio is 0.00. Revenue is $0.
Is TRIB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TRIB. It does not provide personalized investment advice.
TRIB

TRIB